ARALEZ PHARMACEUTICALS INC. Additional Paid in Capital
ARALEZ PHARMACEUTICALS INC. had Additional Paid in Capital of $365.61 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2018-05-08
- 2018-03-31: Additional Paid in Capital $365.61M.
- 2017-12-31: Additional Paid in Capital $363.79M.
- 2017-09-30: Additional Paid in Capital $361.18M.
- 2017-06-30: Additional Paid in Capital $358.22M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2018-03-31 | $365.61M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $363.79M 10-Q · filed 2018-05-08 | |
| 2017-09-30 | $361.18M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $358.22M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $355.27M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $352.34M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $349.01M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $345.52M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $342.65M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $149.44M 10-K · filed 2017-03-13 | $1.00 10-K · filed 2016-03-15 |